IRE for liver cancer patients
Part of Cancer, Digestive system clinical trials.
This trial tests a treatment called IRE (irreversible electroporation) for people with liver cancer that hasn't spread. It uses electrical pulses to destroy tumors without heat or cold, and you may qualify if you have up to 3 small tumors and are otherwise healthy enough for the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have liver cancer (HCC) that has not spread outside your liver.
- Your liver function is good (Child-Pugh A).
- Your overall health is fair (ECOG score 0 to 2).
- You have up to 3 tumors, each smaller than 3 cm, that can be treated with IRE.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment called IRE (a type of non-thermal ablation) for colorectal cancer that has spread to the liver. It aims to see if IRE can safely and effectively treat these liver tumors, offering a possible option for patients who may not be candidates for surgery or thermal ablation.
This trial tests a new type of treatment using low-energy radio waves (called electromagnetic fields) for people with advanced liver cancer that can't be removed by surgery. The goal is to see if adding this therapy can help your immune system fight the cancer better.
This trial tests a treatment called radioembolization for small liver cancers. Radioembolization delivers tiny radioactive beads to the tumor, and the goal is to see if it helps shrink or control the cancer.
This study tests a computer-guided microwave ablation procedure to destroy liver tumors. If you have early-stage liver cancer with up to 5 tumors, and one is 2-5 cm in size, you may be a candidate.
This trial tests two procedures—irreversible electroporation and stereotactic body radiotherapy—for people whose colorectal cancer has spread to the liver (1–3 tumors near major blood vessels or bile ducts) and can't be surgically removed or treated with heat. The goal is to see if these approaches can safely destroy those hard-to-reach tumors.
This study looks back at people with advanced pancreatic cancer who received a treatment called IRE (a special type of ablation) along with immunotherapy. The goal is to see how well this combination works and how safe it is for patients whose cancer cannot be removed with surgery.
Hear when a new Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.